Holen Sie sich die Stockscreener-App
4.48
1.10%
-0.05
Handel nachbörslich:
4.43
-0.05
-1.12%
Macrogenics Inc Aktie (MGNX) Neueste Nachrichten
MacroGenics to sell manufacturing operations to Bora for $122.5M - MSN
MacroGenics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
How The MacroGenics (MGNX) Story Is Shifting With ADC Hopes And Execution Risks - Yahoo Finance
MacroGenics stock (US5562221046): insider equity grants follow 2026 shareholder meeting - AD HOC NEWS
MacroGenics Shareholders Back Board, Auditors and Equity Plan - TipRanks
MACROGENICS (MGNX) director O'Brien receives RSUs and 22,000-share option grant - Stock Titan
MacroGenics (MGNX) director receives new options and RSU awards - Stock Titan
MacroGenics (MGNX) director granted options, RSUs and stock - Stock Titan
MacroGenics (MGNX) director converts 3,750 RSUs into common shares - Stock Titan
MacroGenics (MGNX) director awarded options, RSUs and exercises prior grant - Stock Titan
MACROGENICS (MGNX) director Meenu Chhabra gets RSUs, options and RSU vesting - Stock Titan
MACROGENICS (MGNX) director granted options, RSUs and exercises awards - Stock Titan
MACROGENICS (MGNX) director David C. Stump gets new options and RSUs - Stock Titan
MacroGenics (MGNX) director granted options and RSUs, RSUs vest into shares - Stock Titan
MacroGenics (MGNX) awards stock options and RSUs to director Koenig - Stock Titan
MacroGenics (MGNX) investors back board slate and expand 2023 equity plan - Stock Titan
MacroGenics stock (US5562221046): biotech shares jump after Vyloy FDA approval and takeover deal - AD HOC NEWS
Macrogenics (MGNX) News Flow - Moomoo
Macrogenics(MGNX) Stock Options Chain | Quotes & News - Moomoo
MacroGenics stock (US5562221046): FDA hold lifted and shares among May’s biotech gainers - AD HOC NEWS
MacroGenics (MGNX) price target increased by 50.00% to 6.12 - MSN
MacroGenics gains removal of FDA partial hold on lead program - MSN
Bora Group to acquire MacroGenics manufacturing for 122.5 million - MSN
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
Bora to acquire MacroGenics‘ biologics manufacturing facility in Maryland - megaproject.com
MacroGenics sells manufacturing arm to Bora in $123m deal - The Pharma Letter
MacroGenics, Inc.Common Stock (NQ: MGNX - The Chronicle-Journal
Armistice Capital (MGNX) reports 6.01M-share, 9.46% stake in Macrogenics - Stock Titan
MacroGenics, Inc. (NASDAQ:MGNX) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
MacroGenics Reaches US$219m Market Cap Benefiting Insider Stock Buying - Moomoo
Millennium Group reports 3.07M-share stake in MacroGenics (MGNX) - Stock Titan
Bank of America (NASDAQ: MGNX) reports 5.1% ownership in MacroGenics - Stock Titan
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum - The Manila Times
Macrogenics Cash, Cash Equivalents and Marketable Securities Balance of $154.2 M as of March 31 >MGNX - Moomoo
Bora Pharmaceuticals to Acquire MacroGenics Manufacturing Facility in $122.5 Million Deal - biobuzz.io
Barclays Maintains Macrogenics(MGNX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Key facts: MacroGenics Q1 +58% revenue; $36.8M loss; LINNET 4 responses - TradingView
Is MacroGenics (MGNX) 10.6% Undervalued After Q1 2026 Beat? EPS - GuruFocus
MacroGenics (MGNX) reports Q1 loss, tops revenue estimates - MSN
MacroGenics Inc earnings missed by $0.01, revenue topped estimates - Investing.com South Africa
MacroGenics (MGNX) Reports Strong Q1 Revenue and Strategic Movem - GuruFocus
MacroGenics Inc earnings missed by $0.01, revenue topped estimates By Investing.com - Investing.com India
MGNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
MacroGenics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
MacroGenics : Reports First Quarter 2026 Financial Results and Highlights Business Transformation Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and development Manufacturing divestiture and expanded m - marketscreener.com
MacroGenics reports Q1 2026 loss of $36.8M; revenue rises to $20.8M, cash runway extended through 2028 - TradingView
MACROGENICS ($MGNX) Releases Q1 2026 Earnings - Quiver Quantitative
MacroGenics: Q1 Earnings Snapshot - marketscreener.com
MacroGenics (NASDAQ: MGNX) monetizes assets, extends cash runway to 2028 - Stock Titan
MacroGenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation - The Manila Times
MacroGenics (NASDAQ: MGNX) grows revenue and extends cash runway - Stock Titan
Press Release: MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation - Moomoo
Bora Group to acquire MacroGenics manufacturing for $122.5 millionVietnam Investment Review - Vietnam Investment Review - VIR
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):